
Work Here?
Doximity is a digital platform for United States healthcare professionals, offering a professional social network, a residency navigator, and telehealth services. Users join to connect with peers, share medical insights, track residency applications, and conduct remote patient visits. Revenue comes from targeted advertising to medical professionals, premium subscriptions, and telehealth usage fees. Its goal is to improve communication and collaboration among clinicians, support career development and residency placement, and expand access to care through convenient telehealth.
Industries
Enterprise Software
Healthcare
Company Size
501-1,000
Company Stage
IPO
Headquarters
San Francisco, California
Founded
2010
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$687.8M
Above
Industry Average
Funded Over
4 Rounds
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
401(k) Retirement Plan
401(k) Company Match
Family Planning Benefits
Paid Vacation
Paid Holidays
Wellness Program
Doximity has been named a founding partner in Fireworks' new Specialized Intelligence Index, a collection of leading AI benchmarks across industries. The digital platform for US medical professionals launched Bedside Bench, an open-source benchmark measuring clinical-grade AI performance. Bedside Bench tests AI systems using realistic clinical scenarios rather than multiple-choice questions. It evaluates drug safety, evidence application, health equity, and the ability to identify appropriate medical actions whilst avoiding inappropriate ones. When independently assessed by Fireworks, Doximity Ask ranked first against frontier AI models. This follows its top performance amongst US-based models in July's NOHARM study from Stanford and Harvard researchers. The Index also includes domain-specific benchmarks from Harvey for law and Sierra for customer support. Doximity's network includes over 85% of US physicians.
INVESTOR ALERT: Pomerantz law Firm reminds investors with losses on their investment in Doximity, Inc. of class action lawsuit and upcoming deadlines - DOCS. Sep 17, 2026, 19:11 ET NEW YORK, Sept. 17, 2026 /PRNewswire/ - Pomerantz LLP announces that a class action lawsuit has been filed against Doximity, Inc. ("Doximity" or the "Company") (NYSE: DOCS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. The class action concerns whether Doximity and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. You have until November 16, 2026, to ask the Court to appoint you as Lead Plaintiff for the class if you purchased or otherwise acquired Doximity securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com. On November 6, 2025, despite reporting strong second quarter results, Doximity expressed a degree of caution regarding the outlook for ad spending and implied a slowdown in sales growth in the second half of the 2026 fiscal year, which ended on March 31, 2026. On this news, Doximity's stock price fell $8.29 per share, or 13.25%, to close at $54.29 per share on November 7, 2025. Then, on February 5, 2026, Doximity lowered its revenue guidance for 2026 full fiscal year, which ended on March 31, 2026, and announced that its sales growth had decelerated while its net income had contracted, which will negatively impact its 2026 fiscal fourth quarter. On this news, Doximity's stock price fell $5.59 per share, or 16.78%, to close at $27.73 per share on February 6, 2026. Finally, on May 13, 2026, Doximity announced that it missed its already-reduced revenue guidance and projected a significantly slower pace of growth for its 2027 fiscal year, which ends on March 31, 2027. As a result, several analysts downgraded Doximity stock citing issues specific to the Company's business. On this news, Doximity's stock price fell $5.38 per share, or 23%, to close at $18.01 per share on May 14, 2026. Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com. Attorney advertising. Prior results do not guarantee similar outcomes. SOURCE Pomerantz LLP
Novant Health partners with Doximity to bring evidence-based clinical AI into Epic. Novant Health has adopted Doximity Ask, integrating real-time, evidence-based clinical answers directly into Epic for its clinicians. Led by the system's Clinical Informatics Institute and Institute for AI & Innovation, the rollout is part of a broader strategy to give care teams dependable augmented-intelligence tools that keep patient safety and privacy intact. What the clinical teams get. Doximity Ask gives clinicians fast, evidence-based answers to clinical questions at the point of care, grounded in peer-reviewed medical literature, clinical guidelines, and PeerCheck(TM) physician reviews. It was ranked highest for safety among U.S. clinical AI tools in an independent Stanford/Harvard study. At Novant Health, those answers surface directly inside Epic, so clinicians find trusted information without leaving their workflow. Why it matters to Novant Health. "Artificial intelligence is poised to create the greatest impact on clinical care in our lifetime, increasing the speed with which large volumes of data can be consumed or analyzed, used to advance research and tailor care to specific patient needs," said Jason Connelly, MD, MSPH, interim chief health informatics officer at Novant Health. "However, open-source tools do not meet the standards of reliability or confidentiality that clinicians require to ensure patient safety and privacy is upheld." For Novant Health, the case for adopting Ask comes down to how technology gets implemented, not just what it can do. "The future of healthcare will be shaped not only by innovation, but by the responsibility with which it is implemented," Connelly said. "By equipping care teams with evidence-based tools, we're helping clinicians spend more time focused on what matters most: delivering safe, high-quality patient care."
Penn Highlands Healthcare partners with Doximity to launch system-wide clinical AI suite. Penn Highlands Healthcare has adopted Doximity's clinical AI suite, Doximity Dialer, Doximity Ask, and Doximity Scribe, across its nine hospitals, replacing a patchwork of separate tools with a single set that handles patient calls, clinical questions, and visit documentation. For a system that has served Pennsylvania communities for more than a century, the logic is simple: give clinicians technology that works at the point of care without pulling their attention away from the patient in front of them. What the clinical teams get. Doximity Dialer, a secure, HIPAA-compliant telehealth platform, lets staff call patients from any device while showing a verified Penn Highlands number on caller ID, with no downloads or logins for patients to join a video visit. Doximity Ask is a HIPAA-compliant clinical AI, purpose-built for medicine, giving clinicians verified answers at the point of care and handling the documentation and administrative work that should not be consuming their day. An independent Stanford/Harvard study ranked it highest for safety among U.S. clinical AI tools. Doximity Scribe is an ambient AI documentation assistant that generates notes during in-person and virtual visits, giving physicians back time for face-to-face conversation with patients. Why it matters to Penn Highlands. "Doximity offers tailored ways to optimize search output and streamline processes for our entire system," said Russell Cameron, MD, chief medical information officer for Penn Highlands Healthcare. "By bringing these new technologies together under a unified platform, Penn Highlands Healthcare continues to modernize its care delivery framework. This partnership ensures clinicians spend less time navigating software and more time focused on delivering personalized, high-quality care to patients across the region." The system-wide adoption reflects how health systems are approaching clinical technology today. "Penn Highlands Healthcare's decision to adopt Doximity's AI-powered clinical tools across nine hospitals reflects a broader shift of health systems moving to fewer, vetted and trusted tools, not a patchwork of point solutions," said Aaron Kornetzke, general manager of enterprise solutions at Doximity. "We're proud to help their physicians be more productive and deliver better care to their patients."
Timothy Cabral, a director at Doximity, sold 7,500 shares of Class A Common Stock on 7 August through a pre-arranged Rule 10b5-1 trading plan adopted in February. The sale occurred the day after Doximity's stock jumped 33% following earnings, though the timing was automatic rather than discretionary. The transaction reduced Cabral's direct holdings to 3,221 shares, but he retains 326,000 derivative securities. Doximity reported revenue of $156.6 million for the quarter, up 7%, whilst free cash flow fell 34% to $39.6 million. The company attributed the decline to accounts receivable timing. Doximity operates a cloud-based platform for healthcare practitioners and generates revenue through subscriptions from pharmaceutical companies and healthcare organisations. The stock had declined 50% over the prior year before the recent surge.
Find jobs on Simplify and start your career today
Industries
Enterprise Software
Healthcare
Company Size
501-1,000
Company Stage
IPO
Headquarters
San Francisco, California
Founded
2010
Find jobs on Simplify and start your career today